87th European Atherosclerosis Society (EAS) Congress 2019
MECC Maastricht *Maastricht, NETHERLANDS Visit the Venue to read more
On behalf of the European Atherosclerosis Society (EAS) and the Dutch Atherosclerosis Society we invite you to the Netherlands, to the charming and historic city of Maastricht and the 87th EAS Congress. During the meeting we will explore the latest developments in research into the causes of atherosclerosis and related vascular disease, and how these may affect the clinical guidelines for diagnosis and treatment. Clinicians and basic researchers studying atherosclerosis and related vascular disease are welcome to submit an abstract, to present their findings to the international scientific community at EAS 2019.
Join us in Maastricht, and hear leading experts in the award-winning Anitschkow Lecture, Keynote Lectures, Plenary Sessions, Workshops and Advance Clinical Seminars. Come and ask questions and share your own ideas during the Science at a Glance and Poster Sessions. We particularly welcome early-career scientists to take part in the Congress, present their own research, and get to know others in the field. See the Society website for how to apply for Young Investigator Fellowships.
Compact and vibrant, Maastricht is a great networking city. Join us there 26-29 May at EAS 2019! You are sure to gain new friends, new ideas, and inspiration to take your studies of atherosclerosis and related vascular disease to new levels!
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Participants interested in making an oral or poster presentation are invited to submit an abstract. All abstracts will undergo review by the Abstract Review Committee, to determine which abstracts may be accepted. To submit your abstract you will first need to register contact details according to the information below on “Writing & submitting your abstract”.
For questions about the submission, please contact: firstname.lastname@example.org
Accepted abstracts will be invited for presentation in one of the following formats:
as an oral presentation in a workshop session
as an oral communication in a free communication session
as a discussed poster in a science at a glance session
as a discussed poster in the poster exhibition
as a poster presentation in the poster exhibition
Abstract submission and presentation rules
All abstracts submitted via the online submission form before the deadline will be forwarded to the Abstract Review Committee for review.
All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university scientific publications office (or other similar facility) or by a copy editor, prior to submission.
Abstracts submitted by fax or e-mail will not be accepted.
Please do not submit multiple copies of the same abstract.
Confirmation of receipt & notification of decision
You will receive email confirmation that your abstract has been received, indicating the abstract number which it has been allocated. Please refer to this abstract number in all correspondence regarding the abstract.
Please contact the Secretariat if you submit an abstract and do not receive confirmation that it has been received.
Notifications regarding status of your abstract will be sent once the review process is complete.
Presentation at Congress
Instructions for preparation of oral or poster presentations will be sent together with acceptance notifications.
The Committee will endeavour to schedule abstracts according to authors’ preferences but reserves the right to decide on the final form of presentation.
For each abstract, an author is expected to attend the congress and make the poster or oral presentation. Presenting authors must register by the registration deadline March 18, 2019.
Accepted abstracts for which a presenting author is registered and has paid the registration fee by March 18, 2019:
– will be scheduled for presentation and included in the online Congress Scientific Programme.
– will be included in the Congress proceedings in the Society’s journal, Atherosclerosis, in an issue to be published after the Congress.
Abstracts for which no author has registered to attend Congress by March 18, 2019 will not be included in the Congress Scientific Programme.
Writing & submitting your abstract
Please follow the guidance below when writing and submitting your abstract.
The abstract should be as informative as possible:
Aim: state background and specific objective of study
Methods: shortly describe methods used
Results: summarize results obtained
Conclusions: state conclusions reached
Standard abbreviations may be used.
Before you begin, please prepare the following information:
Presenting author’s contact details:
Full postal address
Date of birth
Presentation type – please choose from one of the following:
Author and co-authors’ details:
Full first and family name(s)
Affiliation details: department, institution / hospital, city, state (if relevant), country
Abstract title – Limited to 25 words in Sentence Structure
Abstract text – Limited to 250 words (Please Note: Word count is affected when graphs/tables/images are added).
Abstract topic – Abstracts must be allocated to a specific topic for the Scientific Program. Please choose from the list of topics.
Abstract submission deadline 2019-03-19
You will be given a support category status dependent upon the total amount of your support contribution. The total contribution will consist of items such as advertisements, sponsored sessions and exhibition space (excluding storage space).
You will benefit from outstanding advantages linked to your support category.
Congress registrations 1053
Promotional Posters in the Venue – (location to be coordinated with organizer and subject to approval of Executive Committee, to be provided by the Sponsor)2 Promotional Posters in the venue 1 Promotional Posters in the venue -
Promotion of Educational Symposium through a link in the Congress website√--
Supporter’s logo with the hyperlink on the Congress website √√√
Acknowledgement on Supporters page of Final Programme and Congress App√√√
Acknowledgement on Supporters Board on-site√√√
INDUSTRY BENEFITS OF SUPPORTING EAS 2019
Access and opportunity to interact with experts and key opinion leaders from around the world
Opportunity to promote your company’s research to an international audience.
Opportunity to participate in educational activities and to align with the EAS in promoting improved treatments for cardiovascular disease.
Hear first-hand expert opinions and debates on new international and regional guidelines and consensus statements.
EAS CORPORATE SPONSORSHIP
Priority choice of Educational Symposia slots, exhibition and sponsorship items will be available to the Corporate Partners of the EAS Society
Rue François-Versonnex 7
1207 Geneva, Switzerland
T: +41 22 908 0488